Third Rock Ventures, LLC 13F Holdings · last filed Q3 2015
Third Rock Ventures, LLC reported 5 securities worth $1.07B in its SEC 13F filing for Q3 2015 (period ended 2015-09-30). Top holdings: GBT (58.10%), SAGE (25.46%), BPMC (14.73%). Among its top 25 positions this quarter: 1 new, 2 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | GBT | GLOBAL BLOOD THERAPEUTICS IN | $622.3M | 58.10% | 14.8M | New |
| 2 | SAGE | SAGE THERAPEUTICS INC | $272.7M | 25.46% | 6.4M | Trimmed |
| 3 | BPMC | BLUEPRINT MEDICINES CORP | $157.8M | 14.73% | 7.4M | Hold |
| 4 | SESN | ELEVEN BIOTHERAPEUTICS INC | $11.7M | 1.09% | 4.8M | Hold |
| 5 | LRMR | ZAFGEN INC | $6.7M | 0.63% | 210,371 | Trimmed |
Source: SEC Form 13F filings · as of 2015-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR